Contraindicated (1)bortezomib will enhance the level or result of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Contraindicated. Robust or reasonable CYP2C19 inhibitors may enhance mavacamten systemic publicity, causing heart failure resulting from systolic dysfunction. Tell your health care provider When you are Expecting or strategy to be pregnant. You should https://lordd443sdn6.webbuzzfeed.com/profile